title: [Treatment with S-1 and radiation therapy for advanced lung cancer invading chest wall].
abstract: The patient was a 63-year-old man, who had been suffering from lung cancer with left chest wall invasion and contralateral pulmonary metastases. Due to the severe pain caused by this advanced lung cancer with poor performance status (PS), oxycodone was administered for treatment. Radiotherapy was used for local tumor control and oral S-1 was given as systemic chemotherapy. The local control rate (near CR) and the PS were improved effectively by this combination of palliative treatment. As a result, he was allowed to return home and followed as an outpatient. Our experience suggests that positive palliative treatment improves the quality of life (QOL) of patients and provides survival benefits.
authors.affiliation: Department of Surgery, Nihon University School of Medicine, Japan.
authors.forename: Motohiko
authors.initials: M
authors.lastname: Furuichi
authors.forename: Takashi
authors.initials: T
authors.lastname: Muramatsu
authors.forename: Mie
authors.initials: M
authors.lastname: Shimamura
authors.forename: Tatsuhiko
authors.initials: T
authors.lastname: Nishii
authors.forename: Shinji
authors.initials: S
authors.lastname: Takeshita
authors.forename: Shinichiro
authors.initials: S
authors.lastname: Ishimoto
authors.forename: Hiroaki
authors.initials: H
authors.lastname: Morooka
authors.forename: Masako
authors.initials: M
authors.lastname: Sodeyama
authors.forename: Kenichi
authors.initials: K
authors.lastname: Sakurai
authors.forename: Sadao
authors.initials: S
authors.lastname: Amano
authors.forename: Ikko
authors.initials: I
authors.lastname: Ohmori
authors.forename: Motomi
authors.initials: M
authors.lastname: Shiono
mesh_terms: D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D004338:Drug Combinations; D006801:Humans; D008175:Lung Neoplasms / Q000473:pathology* / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D009361:Neoplasm Invasiveness; D010094:Oxonic Acid / Q000627:therapeutic use*; D011788:Quality of Life; D005641:Tegafur / Q000627:therapeutic use*; D013899:Thoracic Neoplasms / Q000556:secondary*; D035441:Thoracic Wall
chemical_list: D000964:Antimetabolites, Antineoplastic; D004338:Drug Combinations; C079198:S 1 (combination); D005641:Tegafur; D010094:Oxonic Acid